Sari Fishman
Corporate Officer/Principal en CAN-FITE BIOPHARMA LTD. .
Fortuna: - $ al 30/04/2024
Cargos activos de Sari Fishman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01/01/2014 | - |
| Director Técnico/Científico/I+D | 01/01/2004 | 01/01/2014 |
Historial de carrera de Sari Fishman
Antiguos cargos conocidos de Sari Fishman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Director Técnico/Científico/I+D | - | - |
Formación de Sari Fishman.
| Bar-Ilan University | Doctorate Degree |
Estadísticas
Internacional
| Israel | 4 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Sari Fishman
- Experiencia
